Myriad Genetics, Inc. reported earnings results for the first quarter ended March 31, 2025. For the first quarter, the company reported sales was USD 195.9 million compared to USD 202.2 million a year ago. Net loss was USD 0.1 million compared to USD 26 million a year ago.